pluripotent stem cell (PSC)-derived therapies

This lineup at ISSCR 2026 provides comprehensive coverage of the pluripotent stem cell (PSC) -derived cell therapy pipeline, from preclinical research, clinical translation, and commercial manufacturing, along with enabling technologies to drive the next breakthrough. Register for ISSCR 2026 to hear these presentations.

A brightly colored microscopic image of a spherical cluster of cells with purple, pink, green, and red staining, against a black background.

Register for ISSCR 2026

Roger A. Barker, PhD, MRCP

University of Cambridge, UK
Presenting in Plenary IV: Clinical Advances and the Promise for Patient
Faranak Fattahi, PhD

University of California, San Francisco, USA
Presenting in Modeling Cellular Complexity for Tissue Therapies
Michael A. Laflamme, MD, PhD

McEwen Stem Cell Institute, University Health Network, Canada
Presenting in Tissue Repair and Regeneration in Common Diseases
Martine Rothblatt, JD, PhD

United Therapeutics, USA
Presenting in Plenary IV: Clinical Advances and the Promise for Patients
Guy Sauvageau, PhD

Institute for Research in Immunology & Cancer, Université de Montréal, Canada
Presenting in Modulating the Tissue Niche for Therapeutic Success
Nobukatsu Sawamoto, MD, PhD

Kyoto University, Japan
Presenting in Modulating the Tissue Niche for Therapeutic Success
Hanne Scholz, PhD

Uppsala University and Oslo University Hospital, Sweden
Presenting in Tissue Repair and Regeneration in Common Diseases
Mark Skylar-Scott, PhD

Stanford University, USA
Presenting in Biomanufacturing Stem Cell Therapies
Peter Zandstra, PhD, FRSC, PEng

The University of British Columbia, Canada
Presenting in Engineering Cell Fate in Biological Systems

Explore other scientific topics covered at ISSCR 2026